MBNL3 Acts as a Target of miR-302e to Facilitate Cell Proliferation, Invasion and Angiogenesis of Gastric Adenocarcinoma via AKT/VEGFA Pathway
Journal of Microbiology and Biotechnology · 2024
DOI: 10.4014/jmb.2401.01027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2024. Verfasst von Weiping Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Chaohu Hospital of Anhui Medical University, Chaohu 238000, Anhui, P.R. China. Hauptthemen laut MEDLINE: MicroRNAs, Stomach Neoplasms, Cell Proliferation, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Anhui Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Chaohu Hospital of Anhui Medical University, Chaohu 238000, Anhui, P.R. China.
Förderung
- Anhui Medical University
Zitieren
APA
Tang, W., Huang, C., Jiang, B., Lin, J., & Lu, Y. (2024). MBNL3 Acts as a Target of miR-302e to Facilitate Cell Proliferation, Invasion and Angiogenesis of Gastric Adenocarcinoma via AKT/VEGFA Pathway. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2401.01027
Vancouver
Tang W, Huang C, Jiang B, Lin J, Lu Y. MBNL3 Acts as a Target of miR-302e to Facilitate Cell Proliferation, Invasion and Angiogenesis of Gastric Adenocarcinoma via AKT/VEGFA Pathway. Journal of Microbiology and Biotechnology. 2024. doi:10.4014/jmb.2401.01027
BibTeX
@article{Tang2024,
author = {Tang, Weiping and Huang, Can and Jiang, Bing and Lin, Junjun and Lu, Yecai},
title = {MBNL3 Acts as a Target of miR-302e to Facilitate Cell Proliferation, Invasion and Angiogenesis of Gastric Adenocarcinoma via AKT/VEGFA Pathway},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
doi = {10.4014/jmb.2401.01027}
}
EUVIMED